Memory B cells (MBCs) provide protection against the consequences of reexposure to antigen 1,2,3. These cells can differentiate into antibody-forming cells (AFCs) and make new antibodies or can enter ...
Low-dose versus standard-dose gemcitabine infusion and cisplatin for patients with advanced bladder cancer: A randomized phase II trial: An update. Impact of response to prior chemotherapy (RTPC) on ...
Comprehensive genomic profiling of 443 patients with advanced renal cell carcinoma (RCC) to reveal clinically relevant genomic alterations and to aid in classification of rare subtypes. This is an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback